$TKMR Recent News Newscast: Stocks finish the
Post# of 94281
Posted On: 08/11/2014 1:06:52 PM
$TKMR Recent News
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
Jim Cramer Answers Twitter (TWTR) Questions on Tesla (TSLA), Tekmira (TKMR), Alcoa (AA) and SolarCity (SCTY) 53 min ago - TheStreet.com
Heavy Early Morning Activity On Tekmira Pharmaceuticals (TKMR) 9:07 a.m. Today - TheStreet.com
Cramer's Lightning Round - Everyone Is Panicking About Rite Aid (8/8/14) 6:24 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: I'm Not Selling Rite-Aid 6:00 a.m. Aug. 9, 2014 - TheStreet.com
'Fast Money' Recap: Have the Markets Hit Bottom? 5:00 a.m. Aug. 9, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:15 p.m. Aug. 8, 2014 - TheStreet.com
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today (Update) 4:36 p.m. Aug. 8, 2014 - TheStreet.com
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP 3:54 p.m. Aug. 8, 2014 - Zacks.com
Today's big post-earnings-report movers 3:49 p.m. Aug. 8, 2014 - Seeking Alpha
Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars 1:04 p.m. Aug. 8, 2014 - Investors Business Daily
Update: Tekmira Clinical Hold Lifted 11:38 a.m. Aug. 8, 2014 - Seeking Alpha
Today's Market: News Moving These Names 11:09 a.m. Aug. 8, 2014 - Seeking Alpha
Tekmira up premarket after FDA alters TKM-Ebola IND status 7:15 a.m. Aug. 8, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Says FDA Modifies Hold On Ebola Application 6:38 a.m. Aug. 8, 2014 - benzinga.com
'Fast Money' Recap: Still Pressured by Russia 5:00 a.m. Aug. 8, 2014 - TheStreet.com
FDA gives Tekmira a clinical hold letter instead a green light for Ebola trial 4:23 p.m. Aug. 7, 2014 - Seeking Alpha
Sarepta Should Shut Up About Ebola, Focus on Job No. 1 12:07 p.m. Aug. 6, 2014 - TheStreet.com
Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress - Analyst Blog 12:00 p.m. Aug. 6, 2014 - Zacks.com
Tekmira Pharma in Focus as the World Awaits Ebola Treatment - Analyst Blog 6:34 p.m. Aug. 5, 2014 - Zacks.com
Sarepta Ready to Provide Ebola Drug if Needed 12:50 p.m. Aug. 5, 2014 - Barrons.com
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 10:25 a.m. April 1, 2014 - GlobeNewswire
Tekmira Announces Completion of Underwritten Public Offering of Common Stock 1:54 p.m. March 18, 2014 - GlobeNewswire
Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 9:02 a.m. March 13, 2014 - GlobeNewswire
Tekmira Announces Proposed Public Offering of Common Stock 4:40 p.m. March 10, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces Year-End 2013 Results 8:30 a.m. March 6, 2014 - GlobeNewswire
Tekmira Receives Fast Track Designation From FDA for Its Anti-Ebola Viral Therapeutic 5:07 p.m. March 5, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and 2013 Year-End Financial Results 5:07 p.m. March 4, 2014 - GlobeNewswire
Tekmira Presents Recent Advances in mRNA Delivery at Scientific Symposium 5:48 a.m. Feb. 25, 2014 - GlobeNewswire
DoD's Joint Project Manager Medical Countermeasure Systems (JPM-MCS) Announces Start of Human Clinical Trial for Ebola Therapeutic 8:00 a.m. Feb. 24, 2014 - PR Newswire - PRF
Tekmira Announces Filing of Shelf Prospectus and Registration Statement 3:55 p.m. Feb. 21, 2014 - GlobeNewswire
Webcast Advisory: Tekmira to Present at the 2014 RBC Capital Markets' Global Healthcare Conference 6:10 p.m. Feb. 20, 2014 - GlobeNewswire
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
Jim Cramer Answers Twitter (TWTR) Questions on Tesla (TSLA), Tekmira (TKMR), Alcoa (AA) and SolarCity (SCTY) 53 min ago - TheStreet.com
Heavy Early Morning Activity On Tekmira Pharmaceuticals (TKMR) 9:07 a.m. Today - TheStreet.com
Cramer's Lightning Round - Everyone Is Panicking About Rite Aid (8/8/14) 6:24 a.m. Today - Seeking Alpha
'Mad Money' Lightning Round: I'm Not Selling Rite-Aid 6:00 a.m. Aug. 9, 2014 - TheStreet.com
'Fast Money' Recap: Have the Markets Hit Bottom? 5:00 a.m. Aug. 9, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan 8:15 p.m. Aug. 8, 2014 - TheStreet.com
Why Tekmira Pharmaceuticals (TKMR) Stock Is Soaring Today (Update) 4:36 p.m. Aug. 8, 2014 - TheStreet.com
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP 3:54 p.m. Aug. 8, 2014 - Zacks.com
Today's big post-earnings-report movers 3:49 p.m. Aug. 8, 2014 - Seeking Alpha
Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars 1:04 p.m. Aug. 8, 2014 - Investors Business Daily
Update: Tekmira Clinical Hold Lifted 11:38 a.m. Aug. 8, 2014 - Seeking Alpha
Today's Market: News Moving These Names 11:09 a.m. Aug. 8, 2014 - Seeking Alpha
Tekmira up premarket after FDA alters TKM-Ebola IND status 7:15 a.m. Aug. 8, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Says FDA Modifies Hold On Ebola Application 6:38 a.m. Aug. 8, 2014 - benzinga.com
'Fast Money' Recap: Still Pressured by Russia 5:00 a.m. Aug. 8, 2014 - TheStreet.com
FDA gives Tekmira a clinical hold letter instead a green light for Ebola trial 4:23 p.m. Aug. 7, 2014 - Seeking Alpha
Sarepta Should Shut Up About Ebola, Focus on Job No. 1 12:07 p.m. Aug. 6, 2014 - TheStreet.com
Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress - Analyst Blog 12:00 p.m. Aug. 6, 2014 - Zacks.com
Tekmira Pharma in Focus as the World Awaits Ebola Treatment - Analyst Blog 6:34 p.m. Aug. 5, 2014 - Zacks.com
Sarepta Ready to Provide Ebola Drug if Needed 12:50 p.m. Aug. 5, 2014 - Barrons.com
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
Tekmira Presents Advances in Anti-Viral Product Platform at Scientific Symposium 10:25 a.m. April 1, 2014 - GlobeNewswire
Tekmira Announces Completion of Underwritten Public Offering of Common Stock 1:54 p.m. March 18, 2014 - GlobeNewswire
Tekmira Announces Pricing of Underwritten Public Offering of Common Stock 9:02 a.m. March 13, 2014 - GlobeNewswire
Tekmira Announces Proposed Public Offering of Common Stock 4:40 p.m. March 10, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces Year-End 2013 Results 8:30 a.m. March 6, 2014 - GlobeNewswire
Tekmira Receives Fast Track Designation From FDA for Its Anti-Ebola Viral Therapeutic 5:07 p.m. March 5, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and 2013 Year-End Financial Results 5:07 p.m. March 4, 2014 - GlobeNewswire
Tekmira Presents Recent Advances in mRNA Delivery at Scientific Symposium 5:48 a.m. Feb. 25, 2014 - GlobeNewswire
DoD's Joint Project Manager Medical Countermeasure Systems (JPM-MCS) Announces Start of Human Clinical Trial for Ebola Therapeutic 8:00 a.m. Feb. 24, 2014 - PR Newswire - PRF
Tekmira Announces Filing of Shelf Prospectus and Registration Statement 3:55 p.m. Feb. 21, 2014 - GlobeNewswire
Webcast Advisory: Tekmira to Present at the 2014 RBC Capital Markets' Global Healthcare Conference 6:10 p.m. Feb. 20, 2014 - GlobeNewswire
(0)
(0)